1. Chemotherapy for advanced ovarian cancer: overview of randomized trials;Thigpen;Semin Oncol,2000
2. Randomized phase III study of cisplatin (CIS)/paclitaxel (PAC) versus carboplatin (CARBO)/PAC in optimal stage III epithelial ovarian cancer (OC): a Gynecologic Oncology Group trial (GOG 158) [abstract 1373];Ozols;Proc ASCO,1999
3. A review of the pharmacokinetics and pharmacodynamics of combination carboplatin/paclitaxel;Calvert;Semin Oncol,1997
4. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer;Jodrell;J Clin Oncol,1992
5. Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting;Gordon;J Clin Oncol,1997